Aryl ureas with angiogenesis inhibiting activity

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/44 (2006.01) A61K 31/17 (2006.01) A61K 31/40 (2006.01) A61K 31/421 (2006.01) A61K 31/426 (2006.01) A61K 31/4436 (2006.01) A61K 31/445 (2006.01) A61K 31/454 (2006.01) A61K 31/4709 (2006.01) A61K 31/4725 (2006.01) A61K 31/496 (2006.01) A61K 31/497 (2006.01) A61K 31/5377 (2006.01) A61K 31/54 (2006.01) A61P 17/06 (2006.01) A61P 19/02 (2006.01) A61P 27/02 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2475703

This invention relates to methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes.

La présente invention a trait à des procédés d'utilisation pour le traitement de maladies causées par la voie de transduction de signal induit par le facteur de croissance endothéliale caractérisée par des processus d'angiogenèse anormale ou d'hyperpermeabilité.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Aryl ureas with angiogenesis inhibiting activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aryl ureas with angiogenesis inhibiting activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl ureas with angiogenesis inhibiting activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1930930

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.